Chronic kidney disease prevalence and associated risk factors in hypertensive adults at Burao general hospital, Burao City, Somaliland: a cross-sectional study
- PMID: 40852204
- PMCID: PMC12367694
- DOI: 10.3389/fcvm.2025.1503233
Chronic kidney disease prevalence and associated risk factors in hypertensive adults at Burao general hospital, Burao City, Somaliland: a cross-sectional study
Abstract
Background: Chronic kidney disease (CKD) is a significant global health challenge, particularly in low- and middle-income countries where hypertension is a prominent risk factor. This study aimed to assess the prevalence of CKD and its associated risk factors among hypertensive adults at the Burao General Hospital in Somaliland, Somalia.
Methods: A cross-sectional study was conducted from January to July 2024, enrolling 262 hypertensive adults using consecutive sampling. Data were collected using structured questionnaires addressing sociodemographic factors, clinical characteristics, and lifestyle choices. Proteinuria levels and estimated glomerular filtration rates were assessed to confirm CKD diagnosis.
Results: The prevalence of CKD among hypertensive patients was 52.67% (95% CI: 46.6%-58.7%). Significant associations were observed between CKD and factors such as age, proteinuria, diabetes, blood pressure control, and body mass index (BMI). Specifically, proteinuria was strongly linked to CKD (AOR: 10.72, 95% CI: 5.74-20.04). Individuals aged 34-41 years (AOR: 3.39, 95% CI: 0.99-11.54) and those classified as overweight (AOR: 3.37, 95% CI: 1.65-6.88) were at greater risk for CKD.
Conclusion: The findings highlight a critical association between hypertension and CKD, emphasizing the need for targeted interventions to effectively manage hypertension and address modifiable risk factors. Understanding these relationships is vital for developing healthcare policies aimed at reducing CKD prevalence among adults in Burao City, Somaliland.
Keywords: Burao; Somaliland; chronic kidney disease; hypertension; proteinuria.
© 2025 Yosef and Ali.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Adolescent Body Mass Index and Early Chronic Kidney Disease in Young Adulthood.JAMA Pediatr. 2024 Feb 1;178(2):142-150. doi: 10.1001/jamapediatrics.2023.5420. JAMA Pediatr. 2024. PMID: 38079159 Free PMC article.
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article.
-
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870148 Free PMC article.
-
Assessment of chronic kidney disease and associated factors at Wolkite University Specialized Hospital: A cross-sectional study.World J Nephrol. 2025 Jun 25;14(2):100896. doi: 10.5527/wjn.v14.i2.100896. World J Nephrol. 2025. PMID: 40568333 Free PMC article.
-
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.Lancet Glob Health. 2025 Aug;13(8):e1378-e1395. doi: 10.1016/S2214-109X(25)00198-6. Lancet Glob Health. 2025. PMID: 40712611
References
LinkOut - more resources
Full Text Sources